Industry Research Reports

Home > Reports > Pharma & Healthcare > Tacrolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Tacrolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-24

Pages: 167 Pages

Report ld: 2340449

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Tacrolimus was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tacrolimus was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Tacrolimus was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Tacrolimus include GSK, Abbott, Roche Pharma, Novartis, Mylan, Squibb, Astellas, Aarti Group and Takeda, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Tacrolimus, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tacrolimus by region & country, by Type, and by Application.

The Tacrolimus market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tacrolimus.

Market Segmentation

Report Metric
Details
Report Title
Tacrolimus - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Global Tacrolimus Companies Covered
GSK, Abbott, Roche Pharma, Novartis, Mylan, Squibb, Astellas, Aarti Group, Takeda, Huapont Pharma, Senju Pharmaceutical, Guike Pharmaceutical, Tecoland, Sandoz, ScinoPharm, RPG Life Science, Suzhou Pharmaceutical Technology, Accura Pharmaceuticals, Fujisawa Pharmaceutical, Sichuan Med-Shine Pharmaceutical, Sinopharm Chuankang Pharmaceutical, Yamanouchi Pharmaceutical, Zhongmei Huadong Pharmaceutical, Hisun Pharmaceutical
Global Tacrolimus Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Tacrolimus Market, Segment by Type
Tacrolimus Capsules

Tacrolimus Ointment

Tacrolimus Injection
Global Tacrolimus Market, Segment by Application
Hospitals

Clinics

Other
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Tacrolimus manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Tacrolimus in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Tacrolimus in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Tacrolimus Product Introduction
    1.2 Global Tacrolimus Market Size Forecast
        1.2.1 Global Tacrolimus Sales Value (2019-2030)
        1.2.2 Global Tacrolimus Sales Volume (2019-2030)
        1.2.3 Global Tacrolimus Sales Price (2019-2030)
    1.3 Tacrolimus Market Trends & Drivers
        1.3.1 Tacrolimus Industry Trends
        1.3.2 Tacrolimus Market Drivers & Opportunity
        1.3.3 Tacrolimus Market Challenges
        1.3.4 Tacrolimus Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Tacrolimus Players Revenue Ranking (2023)
    2.2 Global Tacrolimus Revenue by Company (2019-2024)
    2.3 Global Tacrolimus Players Sales Volume Ranking (2023)
    2.4 Global Tacrolimus Sales Volume by Company Players (2019-2024)
    2.5 Global Tacrolimus Average Price by Company (2019-2024)
    2.6 Key Manufacturers Tacrolimus Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Tacrolimus Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Tacrolimus
    2.9 Tacrolimus Market Competitive Analysis
        2.9.1 Tacrolimus Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Tacrolimus Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Tacrolimus Capsules
        3.1.2 Tacrolimus Ointment
        3.1.3 Tacrolimus Injection
    3.2 Global Tacrolimus Sales Value by Type
        3.2.1 Global Tacrolimus Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Tacrolimus Sales Value, by Type (2019-2030)
        3.2.3 Global Tacrolimus Sales Value, by Type (%) (2019-2030)
    3.3 Global Tacrolimus Sales Volume by Type
        3.3.1 Global Tacrolimus Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Tacrolimus Sales Volume, by Type (2019-2030)
        3.3.3 Global Tacrolimus Sales Volume, by Type (%) (2019-2030)
    3.4 Global Tacrolimus Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Hospitals
        4.1.2 Clinics
        4.1.3 Other
    4.2 Global Tacrolimus Sales Value by Application
        4.2.1 Global Tacrolimus Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Tacrolimus Sales Value, by Application (2019-2030)
        4.2.3 Global Tacrolimus Sales Value, by Application (%) (2019-2030)
    4.3 Global Tacrolimus Sales Volume by Application
        4.3.1 Global Tacrolimus Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Tacrolimus Sales Volume, by Application (2019-2030)
        4.3.3 Global Tacrolimus Sales Volume, by Application (%) (2019-2030)
    4.4 Global Tacrolimus Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Tacrolimus Sales Value by Region
        5.1.1 Global Tacrolimus Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Tacrolimus Sales Value by Region (2019-2024)
        5.1.3 Global Tacrolimus Sales Value by Region (2025-2030)
        5.1.4 Global Tacrolimus Sales Value by Region (%), (2019-2030)
    5.2 Global Tacrolimus Sales Volume by Region
        5.2.1 Global Tacrolimus Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Tacrolimus Sales Volume by Region (2019-2024)
        5.2.3 Global Tacrolimus Sales Volume by Region (2025-2030)
        5.2.4 Global Tacrolimus Sales Volume by Region (%), (2019-2030)
    5.3 Global Tacrolimus Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Tacrolimus Sales Value, 2019-2030
        5.4.2 North America Tacrolimus Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Tacrolimus Sales Value, 2019-2030
        5.5.2 Europe Tacrolimus Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Tacrolimus Sales Value, 2019-2030
        5.6.2 Asia Pacific Tacrolimus Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Tacrolimus Sales Value, 2019-2030
        5.7.2 South America Tacrolimus Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Tacrolimus Sales Value, 2019-2030
        5.8.2 Middle East & Africa Tacrolimus Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Tacrolimus Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Tacrolimus Sales Value
        6.2.1 Key Countries/Regions Tacrolimus Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Tacrolimus Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Tacrolimus Sales Value, 2019-2030
        6.3.2 United States Tacrolimus Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Tacrolimus Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Tacrolimus Sales Value, 2019-2030
        6.4.2 Europe Tacrolimus Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Tacrolimus Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Tacrolimus Sales Value, 2019-2030
        6.5.2 China Tacrolimus Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Tacrolimus Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Tacrolimus Sales Value, 2019-2030
        6.6.2 Japan Tacrolimus Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Tacrolimus Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Tacrolimus Sales Value, 2019-2030
        6.7.2 South Korea Tacrolimus Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Tacrolimus Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Tacrolimus Sales Value, 2019-2030
        6.8.2 Southeast Asia Tacrolimus Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Tacrolimus Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Tacrolimus Sales Value, 2019-2030
        6.9.2 India Tacrolimus Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Tacrolimus Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 GSK
        7.1.1 GSK Company Information
        7.1.2 GSK Introduction and Business Overview
        7.1.3 GSK Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 GSK Tacrolimus Product Offerings
        7.1.5 GSK Recent Development
    7.2 Abbott
        7.2.1 Abbott Company Information
        7.2.2 Abbott Introduction and Business Overview
        7.2.3 Abbott Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Abbott Tacrolimus Product Offerings
        7.2.5 Abbott Recent Development
    7.3 Roche Pharma
        7.3.1 Roche Pharma Company Information
        7.3.2 Roche Pharma Introduction and Business Overview
        7.3.3 Roche Pharma Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 Roche Pharma Tacrolimus Product Offerings
        7.3.5 Roche Pharma Recent Development
    7.4 Novartis
        7.4.1 Novartis Company Information
        7.4.2 Novartis Introduction and Business Overview
        7.4.3 Novartis Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Novartis Tacrolimus Product Offerings
        7.4.5 Novartis Recent Development
    7.5 Mylan
        7.5.1 Mylan Company Information
        7.5.2 Mylan Introduction and Business Overview
        7.5.3 Mylan Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Mylan Tacrolimus Product Offerings
        7.5.5 Mylan Recent Development
    7.6 Squibb
        7.6.1 Squibb Company Information
        7.6.2 Squibb Introduction and Business Overview
        7.6.3 Squibb Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Squibb Tacrolimus Product Offerings
        7.6.5 Squibb Recent Development
    7.7 Astellas
        7.7.1 Astellas Company Information
        7.7.2 Astellas Introduction and Business Overview
        7.7.3 Astellas Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Astellas Tacrolimus Product Offerings
        7.7.5 Astellas Recent Development
    7.8 Aarti Group
        7.8.1 Aarti Group Company Information
        7.8.2 Aarti Group Introduction and Business Overview
        7.8.3 Aarti Group Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Aarti Group Tacrolimus Product Offerings
        7.8.5 Aarti Group Recent Development
    7.9 Takeda
        7.9.1 Takeda Company Information
        7.9.2 Takeda Introduction and Business Overview
        7.9.3 Takeda Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Takeda Tacrolimus Product Offerings
        7.9.5 Takeda Recent Development
    7.10 Huapont Pharma
        7.10.1 Huapont Pharma Company Information
        7.10.2 Huapont Pharma Introduction and Business Overview
        7.10.3 Huapont Pharma Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.10.4 Huapont Pharma Tacrolimus Product Offerings
        7.10.5 Huapont Pharma Recent Development
    7.11 Senju Pharmaceutical
        7.11.1 Senju Pharmaceutical Company Information
        7.11.2 Senju Pharmaceutical Introduction and Business Overview
        7.11.3 Senju Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.11.4 Senju Pharmaceutical Tacrolimus Product Offerings
        7.11.5 Senju Pharmaceutical Recent Development
    7.12 Guike Pharmaceutical
        7.12.1 Guike Pharmaceutical Company Information
        7.12.2 Guike Pharmaceutical Introduction and Business Overview
        7.12.3 Guike Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.12.4 Guike Pharmaceutical Tacrolimus Product Offerings
        7.12.5 Guike Pharmaceutical Recent Development
    7.13 Tecoland
        7.13.1 Tecoland Company Information
        7.13.2 Tecoland Introduction and Business Overview
        7.13.3 Tecoland Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.13.4 Tecoland Tacrolimus Product Offerings
        7.13.5 Tecoland Recent Development
    7.14 Sandoz
        7.14.1 Sandoz Company Information
        7.14.2 Sandoz Introduction and Business Overview
        7.14.3 Sandoz Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.14.4 Sandoz Tacrolimus Product Offerings
        7.14.5 Sandoz Recent Development
    7.15 ScinoPharm
        7.15.1 ScinoPharm Company Information
        7.15.2 ScinoPharm Introduction and Business Overview
        7.15.3 ScinoPharm Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.15.4 ScinoPharm Tacrolimus Product Offerings
        7.15.5 ScinoPharm Recent Development
    7.16 RPG Life Science
        7.16.1 RPG Life Science Company Information
        7.16.2 RPG Life Science Introduction and Business Overview
        7.16.3 RPG Life Science Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.16.4 RPG Life Science Tacrolimus Product Offerings
        7.16.5 RPG Life Science Recent Development
    7.17 Suzhou Pharmaceutical Technology
        7.17.1 Suzhou Pharmaceutical Technology Company Information
        7.17.2 Suzhou Pharmaceutical Technology Introduction and Business Overview
        7.17.3 Suzhou Pharmaceutical Technology Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.17.4 Suzhou Pharmaceutical Technology Tacrolimus Product Offerings
        7.17.5 Suzhou Pharmaceutical Technology Recent Development
    7.18 Accura Pharmaceuticals
        7.18.1 Accura Pharmaceuticals Company Information
        7.18.2 Accura Pharmaceuticals Introduction and Business Overview
        7.18.3 Accura Pharmaceuticals Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.18.4 Accura Pharmaceuticals Tacrolimus Product Offerings
        7.18.5 Accura Pharmaceuticals Recent Development
    7.19 Fujisawa Pharmaceutical
        7.19.1 Fujisawa Pharmaceutical Company Information
        7.19.2 Fujisawa Pharmaceutical Introduction and Business Overview
        7.19.3 Fujisawa Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.19.4 Fujisawa Pharmaceutical Tacrolimus Product Offerings
        7.19.5 Fujisawa Pharmaceutical Recent Development
    7.20 Sichuan Med-Shine Pharmaceutical
        7.20.1 Sichuan Med-Shine Pharmaceutical Company Information
        7.20.2 Sichuan Med-Shine Pharmaceutical Introduction and Business Overview
        7.20.3 Sichuan Med-Shine Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.20.4 Sichuan Med-Shine Pharmaceutical Tacrolimus Product Offerings
        7.20.5 Sichuan Med-Shine Pharmaceutical Recent Development
    7.21 Sinopharm Chuankang Pharmaceutical
        7.21.1 Sinopharm Chuankang Pharmaceutical Company Information
        7.21.2 Sinopharm Chuankang Pharmaceutical Introduction and Business Overview
        7.21.3 Sinopharm Chuankang Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.21.4 Sinopharm Chuankang Pharmaceutical Tacrolimus Product Offerings
        7.21.5 Sinopharm Chuankang Pharmaceutical Recent Development
    7.22 Yamanouchi Pharmaceutical
        7.22.1 Yamanouchi Pharmaceutical Company Information
        7.22.2 Yamanouchi Pharmaceutical Introduction and Business Overview
        7.22.3 Yamanouchi Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.22.4 Yamanouchi Pharmaceutical Tacrolimus Product Offerings
        7.22.5 Yamanouchi Pharmaceutical Recent Development
    7.23 Zhongmei Huadong Pharmaceutical
        7.23.1 Zhongmei Huadong Pharmaceutical Company Information
        7.23.2 Zhongmei Huadong Pharmaceutical Introduction and Business Overview
        7.23.3 Zhongmei Huadong Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.23.4 Zhongmei Huadong Pharmaceutical Tacrolimus Product Offerings
        7.23.5 Zhongmei Huadong Pharmaceutical Recent Development
    7.24 Hisun Pharmaceutical
        7.24.1 Hisun Pharmaceutical Company Information
        7.24.2 Hisun Pharmaceutical Introduction and Business Overview
        7.24.3 Hisun Pharmaceutical Tacrolimus Sales, Revenue and Gross Margin (2019-2024)
        7.24.4 Hisun Pharmaceutical Tacrolimus Product Offerings
        7.24.5 Hisun Pharmaceutical Recent Development

 8 Industry Chain Analysis
    8.1 Tacrolimus Industrial Chain
    8.2 Tacrolimus Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Tacrolimus Sales Model
        8.5.2 Sales Channel
        8.5.3 Tacrolimus Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Tacrolimus Market Trends
    Table 2. Tacrolimus Market Drivers & Opportunity
    Table 3. Tacrolimus Market Challenges
    Table 4. Tacrolimus Market Restraints
    Table 5. Global Tacrolimus Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Tacrolimus Revenue Market Share by Company (2019-2024)
    Table 7. Global Tacrolimus Sales Volume by Company (2019-2024) & (K MT)
    Table 8. Global Tacrolimus Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Tacrolimus Price by Company (2019-2024) & (USD/MT)
    Table 10. Key Manufacturers Tacrolimus Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Tacrolimus Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Tacrolimus
    Table 13. Global Tacrolimus Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Tacrolimus as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Tacrolimus Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Tacrolimus Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Tacrolimus Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Tacrolimus Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Tacrolimus Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Tacrolimus Sales Volume by Type: 2019 VS 2023 VS 2030 (K MT)
    Table 22. Global Tacrolimus Sales Volume by Type (2019-2024) & (K MT)
    Table 23. Global Tacrolimus Sales Volume by Type (2025-2030) & (K MT)
    Table 24. Global Tacrolimus Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Tacrolimus Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Tacrolimus Price by Type (2019-2024) & (USD/MT)
    Table 27. Global Tacrolimus Price by Type (2025-2030) & (USD/MT)
    Table 28. Global Tacrolimus Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Tacrolimus Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Tacrolimus Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Tacrolimus Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Tacrolimus Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Tacrolimus Sales Volume by Application: 2019 VS 2023 VS 2030 (K MT)
    Table 34. Global Tacrolimus Sales Volume by Application (2019-2024) & (K MT)
    Table 35. Global Tacrolimus Sales Volume by Application (2025-2030) & (K MT)
    Table 36. Global Tacrolimus Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Tacrolimus Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Tacrolimus Price by Application (2019-2024) & (USD/MT)
    Table 39. Global Tacrolimus Price by Application (2025-2030) & (USD/MT)
    Table 40. Global Tacrolimus Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Tacrolimus Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Tacrolimus Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Tacrolimus Sales Value by Region (2019-2024) & (%)
    Table 44. Global Tacrolimus Sales Value by Region (2025-2030) & (%)
    Table 45. Global Tacrolimus Sales Volume by Region (K MT): 2019 VS 2023 VS 2030
    Table 46. Global Tacrolimus Sales Volume by Region (2019-2024) & (K MT)
    Table 47. Global Tacrolimus Sales Volume by Region (2025-2030) & (K MT)
    Table 48. Global Tacrolimus Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Tacrolimus Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Tacrolimus Average Price by Region (2019-2024) & (USD/MT)
    Table 51. Global Tacrolimus Average Price by Region (2025-2030) & (USD/MT)
    Table 52. Key Countries/Regions Tacrolimus Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Tacrolimus Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Tacrolimus Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Tacrolimus Sales Volume, (2019-2024) & (K MT)
    Table 56. Key Countries/Regions Tacrolimus Sales Volume, (2025-2030) & (K MT)
    Table 57. GSK Company Information
    Table 58. GSK Introduction and Business Overview
    Table 59. GSK Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 60. GSK Tacrolimus Product Offerings
    Table 61. GSK Recent Development
    Table 62. Abbott Company Information
    Table 63. Abbott Introduction and Business Overview
    Table 64. Abbott Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 65. Abbott Tacrolimus Product Offerings
    Table 66. Abbott Recent Development
    Table 67. Roche Pharma Company Information
    Table 68. Roche Pharma Introduction and Business Overview
    Table 69. Roche Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 70. Roche Pharma Tacrolimus Product Offerings
    Table 71. Roche Pharma Recent Development
    Table 72. Novartis Company Information
    Table 73. Novartis Introduction and Business Overview
    Table 74. Novartis Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 75. Novartis Tacrolimus Product Offerings
    Table 76. Novartis Recent Development
    Table 77. Mylan Company Information
    Table 78. Mylan Introduction and Business Overview
    Table 79. Mylan Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 80. Mylan Tacrolimus Product Offerings
    Table 81. Mylan Recent Development
    Table 82. Squibb Company Information
    Table 83. Squibb Introduction and Business Overview
    Table 84. Squibb Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 85. Squibb Tacrolimus Product Offerings
    Table 86. Squibb Recent Development
    Table 87. Astellas Company Information
    Table 88. Astellas Introduction and Business Overview
    Table 89. Astellas Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 90. Astellas Tacrolimus Product Offerings
    Table 91. Astellas Recent Development
    Table 92. Aarti Group Company Information
    Table 93. Aarti Group Introduction and Business Overview
    Table 94. Aarti Group Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 95. Aarti Group Tacrolimus Product Offerings
    Table 96. Aarti Group Recent Development
    Table 97. Takeda Company Information
    Table 98. Takeda Introduction and Business Overview
    Table 99. Takeda Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 100. Takeda Tacrolimus Product Offerings
    Table 101. Takeda Recent Development
    Table 102. Huapont Pharma Company Information
    Table 103. Huapont Pharma Introduction and Business Overview
    Table 104. Huapont Pharma Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 105. Huapont Pharma Tacrolimus Product Offerings
    Table 106. Huapont Pharma Recent Development
    Table 107. Senju Pharmaceutical Company Information
    Table 108. Senju Pharmaceutical Introduction and Business Overview
    Table 109. Senju Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 110. Senju Pharmaceutical Tacrolimus Product Offerings
    Table 111. Senju Pharmaceutical Recent Development
    Table 112. Guike Pharmaceutical Company Information
    Table 113. Guike Pharmaceutical Introduction and Business Overview
    Table 114. Guike Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 115. Guike Pharmaceutical Tacrolimus Product Offerings
    Table 116. Guike Pharmaceutical Recent Development
    Table 117. Tecoland Company Information
    Table 118. Tecoland Introduction and Business Overview
    Table 119. Tecoland Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 120. Tecoland Tacrolimus Product Offerings
    Table 121. Tecoland Recent Development
    Table 122. Sandoz Company Information
    Table 123. Sandoz Introduction and Business Overview
    Table 124. Sandoz Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 125. Sandoz Tacrolimus Product Offerings
    Table 126. Sandoz Recent Development
    Table 127. ScinoPharm Company Information
    Table 128. ScinoPharm Introduction and Business Overview
    Table 129. ScinoPharm Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 130. ScinoPharm Tacrolimus Product Offerings
    Table 131. ScinoPharm Recent Development
    Table 132. RPG Life Science Company Information
    Table 133. RPG Life Science Introduction and Business Overview
    Table 134. RPG Life Science Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 135. RPG Life Science Tacrolimus Product Offerings
    Table 136. RPG Life Science Recent Development
    Table 137. Suzhou Pharmaceutical Technology Company Information
    Table 138. Suzhou Pharmaceutical Technology Introduction and Business Overview
    Table 139. Suzhou Pharmaceutical Technology Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 140. Suzhou Pharmaceutical Technology Tacrolimus Product Offerings
    Table 141. Suzhou Pharmaceutical Technology Recent Development
    Table 142. Accura Pharmaceuticals Company Information
    Table 143. Accura Pharmaceuticals Introduction and Business Overview
    Table 144. Accura Pharmaceuticals Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 145. Accura Pharmaceuticals Tacrolimus Product Offerings
    Table 146. Accura Pharmaceuticals Recent Development
    Table 147. Fujisawa Pharmaceutical Company Information
    Table 148. Fujisawa Pharmaceutical Introduction and Business Overview
    Table 149. Fujisawa Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 150. Fujisawa Pharmaceutical Tacrolimus Product Offerings
    Table 151. Fujisawa Pharmaceutical Recent Development
    Table 152. Sichuan Med-Shine Pharmaceutical Company Information
    Table 153. Sichuan Med-Shine Pharmaceutical Introduction and Business Overview
    Table 154. Sichuan Med-Shine Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 155. Sichuan Med-Shine Pharmaceutical Tacrolimus Product Offerings
    Table 156. Sichuan Med-Shine Pharmaceutical Recent Development
    Table 157. Sinopharm Chuankang Pharmaceutical Company Information
    Table 158. Sinopharm Chuankang Pharmaceutical Introduction and Business Overview
    Table 159. Sinopharm Chuankang Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 160. Sinopharm Chuankang Pharmaceutical Tacrolimus Product Offerings
    Table 161. Sinopharm Chuankang Pharmaceutical Recent Development
    Table 162. Yamanouchi Pharmaceutical Company Information
    Table 163. Yamanouchi Pharmaceutical Introduction and Business Overview
    Table 164. Yamanouchi Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 165. Yamanouchi Pharmaceutical Tacrolimus Product Offerings
    Table 166. Yamanouchi Pharmaceutical Recent Development
    Table 167. Zhongmei Huadong Pharmaceutical Company Information
    Table 168. Zhongmei Huadong Pharmaceutical Introduction and Business Overview
    Table 169. Zhongmei Huadong Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 170. Zhongmei Huadong Pharmaceutical Tacrolimus Product Offerings
    Table 171. Zhongmei Huadong Pharmaceutical Recent Development
    Table 172. Hisun Pharmaceutical Company Information
    Table 173. Hisun Pharmaceutical Introduction and Business Overview
    Table 174. Hisun Pharmaceutical Tacrolimus Sales (K MT), Revenue (US$ Million), Price (USD/MT) and Gross Margin (2019-2024)
    Table 175. Hisun Pharmaceutical Tacrolimus Product Offerings
    Table 176. Hisun Pharmaceutical Recent Development
    Table 177. Key Raw Materials Lists
    Table 178. Raw Materials Key Suppliers Lists
    Table 179. Tacrolimus Downstream Customers
    Table 180. Tacrolimus Distributors List
    Table 181. Research Programs/Design for This Report
    Table 182. Key Data Information from Secondary Sources
    Table 183. Key Data Information from Primary Sources
List of Figures
    Figure 1. Tacrolimus Product Picture
    Figure 2. Global Tacrolimus Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Tacrolimus Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Tacrolimus Sales Volume (2019-2030) & (K MT)
    Figure 5. Global Tacrolimus Sales Price (2019-2030) & (USD/MT)
    Figure 6. Tacrolimus Report Years Considered
    Figure 7. Global Tacrolimus Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Tacrolimus Players Sales Volume Ranking (2023) & (K MT)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Tacrolimus Revenue in 2023
    Figure 10. Tacrolimus Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Tacrolimus Capsules Picture
    Figure 12. Tacrolimus Ointment Picture
    Figure 13. Tacrolimus Injection Picture
    Figure 14. Global Tacrolimus Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 15. Global Tacrolimus Sales Value Market Share by Type, 2023 & 2030
    Figure 16. Global Tacrolimus Sales Volume by Type (2019 VS 2023 VS 2030) & (K MT)
    Figure 17. Global Tacrolimus Sales Volume Market Share by Type, 2023 & 2030
    Figure 18. Global Tacrolimus Price by Type (2019-2030) & (USD/MT)
    Figure 19. Product Picture of Hospitals
    Figure 20. Product Picture of Clinics
    Figure 21. Product Picture of Other
    Figure 22. Global Tacrolimus Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Tacrolimus Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Tacrolimus Sales Volume by Application (2019 VS 2023 VS 2030) & (K MT)
    Figure 25. Global Tacrolimus Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Tacrolimus Price by Application (2019-2030) & (USD/MT)
    Figure 27. North America Tacrolimus Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Tacrolimus Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Tacrolimus Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Tacrolimus Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Tacrolimus Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Tacrolimus Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Tacrolimus Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Tacrolimus Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Tacrolimus Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Tacrolimus Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Tacrolimus Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Tacrolimus Sales Volume (%), (2019-2030)
    Figure 39. United States Tacrolimus Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Tacrolimus Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Tacrolimus Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Tacrolimus Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Tacrolimus Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Tacrolimus Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Tacrolimus Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Tacrolimus Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Tacrolimus Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Tacrolimus Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Tacrolimus Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Tacrolimus Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Tacrolimus Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Tacrolimus Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Tacrolimus Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Tacrolimus Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Tacrolimus Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Tacrolimus Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Tacrolimus Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Tacrolimus Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Tacrolimus Sales Value by Application (%), 2023 VS 2030
    Figure 60. Tacrolimus Industrial Chain
    Figure 61. Tacrolimus Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

The global market for Tacrolimus was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.

North American market for Tacrolimus was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Tacrolimus was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Europe market for Tacrolimus was valued at $ million in 2023 and will reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global key companies of Tacrolimus include GSK, Abbott, Roche Pharma, Novartis, Mylan, Squibb, Astellas, Aarti Group and Takeda, etc. In 2023, the global five largest players hold a share approximately % in terms of revenue.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Tacrolimus, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Tacrolimus by region & country, by Type, and by Application.

The Tacrolimus market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Tacrolimus.

Market Segmentation